WOJNILOWICZ, Marcin, Petra LÁZNIČKOVÁ, Yi JU, Ching-Seng ANG, Federico TIDU, Kamila BENDICKOVA, Giancarlo FORTE, Magdalena PLEBANSKI, Frank CARUSO, Francesca CAVALIERI and Jan FRIČ. Influence of protein corona on the interaction of glycogen-siRNA constructs with ex vivo human blood immune cells. BIOMATERIALS ADVANCES. AMSTERDAM: ELSEVIER, 2022, vol. 140, September 2022, p. 1-13. ISSN 2772-9508. Available from: https://dx.doi.org/10.1016/j.bioadv.2022.213083.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Influence of protein corona on the interaction of glycogen-siRNA constructs with ex vivo human blood immune cells
Authors WOJNILOWICZ, Marcin, Petra LÁZNIČKOVÁ (203 Czech Republic, belonging to the institution), Yi JU, Ching-Seng ANG, Federico TIDU (380 Italy), Kamila BENDICKOVA, Giancarlo FORTE (380 Italy), Magdalena PLEBANSKI, Frank CARUSO, Francesca CAVALIERI and Jan FRIČ (203 Czech Republic, guarantor).
Edition BIOMATERIALS ADVANCES, AMSTERDAM, ELSEVIER, 2022, 2772-9508.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30404 Biomaterials
Country of publisher Netherlands
Confidentiality degree is not subject to a state or trade secret
WWW URL
RIV identification code RIV/00216224:14110/22:00128439
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1016/j.bioadv.2022.213083
UT WoS 000861397600003
Keywords in English Glycogen nanoparticles; siRNA glycoplexes; Peripheral blood mononuclear cells; THP-1; Phagocytosis; Protein corona; Stochastic optical reconstruction microscopy
Tags 14110513, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 31/1/2023 12:40.
Abstract
Glycogen-nucleic acid constructs i.e., glycoplexes are emerging promising platforms for the alteration of gene expression and transcription. Understanding the interaction of glycoplexes with human blood components, such as serum proteins and peripheral blood mononuclear cells (PBMCs), is important to overcome immune cell activation and control biodistribution upon administration of the glycoplexes in vivo. Herein, we investigated the interactions of polyethylene glycol (PEG)ylated and non-PEGylated glycoplexes carrying siRNA molecules with PBMCs isolated from the blood of healthy donors. We found that both types of glycoplexes were non-toxic and were primarily phagocytosed by monocytes without triggering a pro-inflammatory interleukin 6 cytokine pro-duction. Furthermore, we investigated the role of the protein corona on controlling the internalization efficiency in immune cells - we found that the adsorption of serum proteins, in particular haptoglobin, alpha-1-antitrypsin and apolipoprotein A-II, onto the non-PEGylated glycoplexes, significantly reduced the uptake of the glycoplexes by PBMCs. Moreover, the non-PEGylated glycoplexes were efficient in the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappa B) knockdown in monocytic THP-1 cell line. This study provides an insight into the rational design of glycogen-based nanocarriers for the safe delivery of siRNA without eliciting unwanted immune cell activation and efficient siRNA activity upon its delivery.
PrintDisplayed: 17/7/2024 16:30